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Abstract
Background: Methicillin-resistant Staphylococcus aureus (MRSA) is responsible for the growing number of hospital- and
community-acquired infections.
Objectives: In this study, we aimed to determine the prevalence of MRSA, its antimicrobial resistance profile, and molecular typing
of strains isolated from different infections in Iran.
Methods: A total of 100 S. aureus strains were isolated from various clinical specimens from Al-Zahra Hospital of Isfahan, Iran during
January-June, 2015. Antimicrobial susceptibility test was performed, using the disk diffusion method. For identifying the MRSA
phenotype, oxacillin agar screening was performed. Detection of mecA gene among the isolates was performed via polymerase
chain reaction (PCR) using specific primers, followed by multiplex PCR for SCCmec typing of MRSA isolates.
Results: In the present study, 54 (54%) isolates were identified as MRSA. Overall, 12 (22.23%) and 42 (77.7%) isolates were obtained from
community- and hospital-acquired infections, respectively. SCCmec typing among MRSA isolates showed that 19 (35.18%), 13 (24.07%),
6 (11.11%), 5 (9.25%), and 3 (5.55%) isolates contained SCCmec type III, type I, type IV, type II, and type V, respectively; however, 8 (14.81%)
isolates were nontypable.
Conclusions: In the current study, SCCmec type III isolates were the most common among 54 MRSA isolates in a teaching hospital
in the center of Iran. This finding might be attributed to antibiotic pressure, facilitating clonal selection.
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1. Background
Staphylococcus aureus (S. aureus) is a major human
pathogen, responsible for both community- and hospital-
acquired infections worldwide. Methicillin resistance is in-
duced by mecA gene, which is located on the staphylococ-
cal cassette chromosome mec (SCCmec), a large heterolo-
gous genetic element, encoding a low-affinity penicillin-
binding protein 2a (PBP2a), which inhibits the activity of
β-lactam antibiotics (1-3).
The increasing prevalence of methicillin-resistant S.
aureus (MRSA) complicates the treatment and manage-
ment of staphylococcal infections (4). Therefore, MRSA
screening is extremely important for epidemiological
surveillance in order to prevent the spread of MRSA infec-
tions. To classify MRSAs, it is necessary to understand their
genetic structure and detect all SCCmec types (2, 5). Al-
though conventional MRSA typing techniques are not ad-
equate for epidemiological surveys, numerous molecular
techniques are available for this purpose (6, 7).
SCCmec typing is a polymerase chain reaction (PCR)-
based method, which is essential for characterization of
MRSA clones in epidemiological studies and provides im-
portant information about the mobile genetic elements
of methicillin resistance (8, 9). SCCmec is an element in-
volved in the horizontal transfer of resistant genes among
Staphylococcus strains. It is also a marker for differentia-
tion between hospital-acquired methicillin-resistant (HA-
MRSA) and community-acquired methicillin-resistant (CA-
MRSA) strains (10-12).
MRSA SCCmec elements have been classified into 5 dif-
ferent allotypes and sometimes show poor discriminatory
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power (12, 13). SCCmec types I, II, and III are usually found in
HA-MRSA and multidrug-resistant (MDR) strains, whereas
CA-MRSA strains are mostly associated with SCCmec type IV
or V (14, 15).
2. Objectives
The main objective of this study was to determine
the prevalence of methicillin resistance among S. aureus
strains, isolated from a teaching hospital in Isfahan and
to identify molecular typing of MRSA isolates through
SCCmec typing method. Such findings could promote ef-
fective infection control and moderate antibiotic use in
hospitals and reduce the prevalence of MRSA in hospitals.
3. Methods
3.1. Bacterial Strains and Phenotypic Test
A total of 100 S. aureus strains were isolated from in-
patients and outpatients, admitted to Al-Zahra Hospital
of Isfahan, Iran during January-June, 2015. The isolates
were obtained from different clinical specimens, includ-
ing wounds, blood samples, urine samples, and abscesses.
S. aureus isolates were identified through culture studies,
as well as morphological and conventional biochemical
tests, including Gram staining, catalase test, mannitol fer-
mentation, slide coagulase test, tube coagulase test, and
DNase test. Then, the isolates were classified as CA-MRSA
or HA-MRSA, based on the recorded data of the patients.
Hospital-acquired infection was defined as bacterial colo-
nization after more than 48 hours of hospitalization.
3.2. Antimicrobial Susceptibility Test
The susceptibility of S. aureus isolates to antimicro-
bial agents was determined by disk diffusion method
on Mueller-Hinton agar medium, according to the clin-
ical and laboratory standards institute (CLSI) guidelines
(16). The used antibiotics were as follows: vancomycin
(30 µg), tetracycline (30 µg), gentamicin (10 µg), clin-
damycin (2 µg), ciprofloxacin (5 µg), rifampin (30 µg), ce-
foxitin (30 µg), levofloxacin (5 µg), and cotrimoxazole (25
µg) (HiMedia, India). Inducible macrolide-lincosamide-
streptogramin B resistance was identified as the flat zone
of clindamycin growth inhibition near the erythromycin
disk (D-shaped). S. aureus strain ATCC25923 was used for
the quality control of antibiotic susceptibility test.
3.3. Phenotypic Detection of MRSA Isolates
All S. aureus isolates were screened for oxacillin resis-
tance, using agar screening method. Resistance to methi-
cillin was defined as the growth capacity in the agar screen-
ing medium, including 4% NaCl and 8 µg/mL of oxacillin
(Sigma, USA). Also, S. aureusATCC 25923 was used as the con-
trol.
3.4. Genotypic Detection of mecA Gene
For this purpose, DNA extraction was performed for
all the isolates, which were grown overnight on nutrient
agar at 37°C, using the K0512 DNA kit (Fermentas, Germany)
in accordance with the manufacture’s instructions. Using
specific primers listed in Table 1, amplification of the 583-
bp fragment of mecA gene was performed through PCR.
The amplification reaction mixture (25 µL) contained
4 µL of DNA template, 2.5 µL of PCR buffer (10X), 0.75 µL of
MgCl2 (50 mM), 0.5 µL of deoxynucleotide triphosphates
(dNTPs, 10 mM), 1 µL of each primer (2 µL in total), 0.25 µL
of Ex-Taq DNA polymerase (5 u/µL), and 15µL of distilled wa-
ter. PCR conditions were as follows: initial denaturation at
94°C for 5 minutes, 30 cycles of denaturation at 94°C for
30 seconds, annealing at 55°C for 30 seconds, extension at
72°C for 30 seconds, and final extension at 72°C for 7 min-
utes.
3.5. Multiplex PCR for SCCmec Typing
SCCmec typing for 54 MRSA isolates was performed via
multiplex PCR method. Primers shown in Table 1 were used
for this purpose. Each PCR round was performed in a final
volume of 25 µL, consisting of 4 µL of DNA template, 2.5
µL of PCR buffer (10X), 0.75 µL of MgCl2 (50 mM), 0.5 µL of
dNTPs (10 mM), 0.5µM of βF1,α3R1, ccrR, and ccrF primers,
0.3 µM of 1272F1, 1272R1, 5RmecA, and 5R431 primers (3.2 µL
in total), 0.25µL of Ex-Taq DNA polymerase (5 u/µL), and 13.8
µL of distilled water.
DNA was amplified with a thermocycler (Eppendorf,
Germany), and multiplex PCR conditions were as follows:
initial denaturation at 94°C for 4 minutes, 35 cycles of de-
naturation at 94°C for 30 seconds, annealing at 55°C for 30
seconds, extension at 72°C for 60 seconds, and final exten-
sion at 72°C for 10 minutes.
4. Results
During 6 months, 100 S. aureus isolates from various
clinical specimens were collected from Al-Zahra Hospital
of Isfahan. The isolates were obtained from urinary tract
infections (UTIs) (n = 23, 23%), blood samples (n = 21, 21%),
wounds (n = 20, 20%), abscesses (n = 14, 14%), and other sam-
ples (n = 22, 22%). The rate of isolation in females and males
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Table 1. Primers Used in the Present Study
Target Primer Sequence Product Size (bp) Reference
mecA
F AAAATCGATGGTAAAGGTTGGC
583 (17)
R AGTTCTGCAGTACCGGATTTG
SCCmec
βF ATTGCCTTGATAATAGCCYTCT
937
(18)
α3R TAAAGGCATCAATGCACAAACACT
ccrCF CGTCTATTACAAGATGTTAAGGATAATCCTTTA
518
ccrCR TAGACTGGATTATTCAAAATAT
1272F1 GCCACTCATAACATATGGAA
1415
1272R1 CATCCGAGTGAAACCCAAA
5RmecA TATACCAAACCCGACAACTAC
359
5R431 CGGCTACAGTGATAACATCC
was 62 (62%) and 38 (38%), respectively. The patients’ aver-
age age was 47 years (range, < 1 - 89 years).
Antimicrobial susceptibility test was performed via
disk diffusion method. The results showed that S. aureus
resistance to cefoxitin (54%) was the highest resistance
rate, followed by tetracycline (52%), gentamicin (30%), clin-
damycin (29%), ciprofloxacin (20%), rifampin (19%), cotri-
moxazole (10%), and levofloxacin (10%). The results indi-
cated that all the isolates were sensitive to vancomycin.
Also, inducible resistance to clindamycin was found in 2
isolates.
In the present study, presence of mecA gene in all the
isolates was evaluated, using the oxacillin agar screening
method and confirmed by molecular methods. The re-
sults showed that 54 (54%) isolates were identified as MRSA,
using the agar screening method (phenotypic detection).
Overall, 13 (24.07%) out of 54 isolates were obtained from
wounds, 10 (18.51%) from blood, 8 (14.81%) from UTI sam-
ples, 6 (11.11%) from abscesses, 5 (9.25%) from trachea, and
12 (22.22%) from other samples.
In this study, we collected 42 (77.7%) MRSA isolates from
inpatients (HA-MRSA) and 12 (22.23) isolates from outpa-
tients (CA-MRSA). The patients with CA-MRSA were younger
than those with HA-MRSA. Among 100 strains tested with
PCR (genotypic detection), 54% were positive for mecA
gene. Finally, to determine the SCCmec type of MRSA iso-
lates, SCCmec typing was evaluated among S. aureus iso-
lates. As the findings revealed, 19 (35.18%), 13 (24.7%), 6
(11.11%), 5 (9.25%), and 3 (5.55%) MRSA isolates contained
SCCmec type III, type I, type IV, type II, and type V, respec-
tively; also, 8 isolates (14.81%) were nontypable.
5. Discussion
Today, MRSA is one of the most frequent nosocomial
pathogens worldwide (19). The rate of antibiotic resis-
tance, including methicillin resistance, is high in develop-
ing countries such as Iran, which might be due to the un-
controlled high rate of antibiotic prescription. The mean
incidence of MRSA infections in Iranian hospitals has been
reported to be 52.7% ± 4.7 (20). Overall, CA-MRSA infec-
tions occurred in healthy individuals outside healthcare
settings without any risk factors and could act as a source
of transfer to community.
On the other hand, recent studies have demonstrated
that the epidemiology of MRSA has changed, and CA-MRSA
strains are now being introduced into the hospital set-
ting. Detection of the epidemiology, clinical syndrome,
and antibiotic resistance of possible CA-MRSA allows early
initiation of treatment and control measures (21, 22). The
prevalence of HA-MRSA in the present study was 77.7% (n
= 42), which is high. In this regard, Stranden et al. and
Moghadami et al. (14, 23) have reported similar findings.
As presented in Table 2, based on the antimicrobial sus-
ceptibility profile in the current study, the highest resis-
tance of S. aureus isolates was reported against cefoxitin
(54%), oxacillin (54%), and tetracycline (52%), followed by
gentamicin (30%), clindamycin (29%), ciprofloxacin (20%),
rifampicin (19%), cotrimoxazole (10%), and levofloxacin
(10%). Incidentally, all the isolates were susceptible to van-
comycin in the present study. These rates were lower than
those reported by Moghadam et al. and Ghasemian et al.
(24, 25).
In the present study, 16% of MRSA isolates were MDR,
which is the main cause of failure in antibiotic therapy
and increasing cost of treatment for patients and health-
care systems throughout the world (20). The phenotypic
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Table 2. Antimicrobial Susceptibility Test
Antibiotics Susceptibility, Number of Isolates (%)
Susceptible Intermediate Resistant
No. % No. % No. %
Ciprofloxacin 66 66 14 14 20 20
Vancomycin 100 100 0 0 0 0
Gentamicin 60 60 10 10 30 30
Clindamycin 66 66 5 5 29 29
Tetracycline 43 43 5 5 52 52
Levofloxacin 82 82 8 8 10 10
Rifampin 76 76 5 5 19 19
Cefoxitin 42 42 4 4 54 54
Cotrimoxazole 87 87 3 3 10 10
methods for MRSA detection are simple and relatively cost-
effective, although they are subjected to variations in envi-
ronmental conditions, such as incubation time, medium
pH, and inoculum size. The associated drawbacks are
among several reasons for replacing these methods with
molecular ones, which are accurate and have good repro-
ducibility (12).
Detection of mecA gene in the present study by PCR
method revealed that phenotypic and genotypic methods
produce similar results regarding the susceptibility of S.
aureus to methicillin (MRSA). The present study showed
that the prevalence of resistant strains to methicillin has
steadily increased in comparison with a previous study
performed in the same hospital (20% vs. 54%) (5, 26). Fur-
thermore, a similar prevalence rate (54%) was reported
by Moghadami et al. in Shiraz, Iran (21). In contrast,
Ghasemian et al. reported a prevalence rate of 25% in
Tehran in 2015, and Orrett et al. showed a prevalence rate
of 20.8% from nosocomial sources in Trinidad (3).
Based on SCCmec typing, MRSA strains are classified
into 5 different allotypes, 2 of which have been identi-
fied in Asian countries. The clonotype II is distributed in
Japan and Korea, whereas clonotype III is predominant in
some other Asian countries, such as Saudi Arabia, India,
China, and Thailand (8, 27, 28). We used SCCmec typing
to monitor the epidemiology of MRSA isolates, collected
from hospital- and community-acquired infections. Distri-
bution of SCCmec types among S. aureus isolates demon-
strated that 19 (35.18%), 13 (24.07%), 6 (11.11%), 5 (9.25%), and 3
(5.55%) strains harbored SCCmec type III, type I, type IV, type
II, and type V, respectively; however, 8 (14.81%) strains were
nontypable (Figure 3).
Similar findings in agreement with the present study
Figure 1. Agarose gel electrophoresis of mecA genes as PCR amplification products.
Lane 1, positive control (S. aureus ATCC33591); lane 2 - 8, positive mecA sample (583
bp); and lane 9, 100-bp DNA ladder.
have been reported by Japoni et al., while contradictory re-
sults have been reported by Pe’rez-Va’zquez et al., Chong-
trakool et al., and Chongtrakool et al. (29). While SCCmec
type III (35.18%) showed the highest prevalence in the
present study, frequency of SCCmec type V (5.55%) was low.
These results were consistent with previous studies per-
formed in Iran and other countries (24, 27, 30, 31).
As expected, SCCmec types V and IV have been overrep-
resented among MRSA strains, isolated from community-
acquired infections. Only 2 isolates with SCCmec type IV
belonged to HA-MRSA, while SCCmec types I, II, and III
were associated with MRSA strains, isolated from hospital-
acquired infections (HA-MRSA) (5, 14). In the present study,
SCCmec typing did not show 100% typeability and had poor
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Figure 2. Agarose gel electrophoresis of SCCmec genes as the multiplex PCR ampli-
fication products in MRSA isolates. Lane 1, SCCmec type II (937 bp); lane 3, 4, 5 and 9,
SCCmec type III (518 bp); lane 6, SCCmec type I (415 bp); lane 7, SCCmec type V (518 and
359 bp); lane 10, 50-bp DNA ladder; and lane 11, SCCmec type IV (415 and 937 bp).
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Figure 3. SCCmec Typing of MRSA Isolated Separately from Community and Hospital
Setting
discriminatory power, as 8 (8%) MRSA isolates were nonty-
pable (32).
Distribution of the isolates on the basis of the speci-
men source revealed that 75% of MRSA strains with SCCmec
type III (as the predominant SCCmec type) were obtained
from blood samples, which is consistent with several pre-
vious studies (27, 33). Overall, these findings propose that
antibiotic pressure and lack of standard control measures
might be responsible for the increased prevalence of MRSA
in Al-Zahra hospital in comparison with the previous study
in this hospital. Also, frequent screening of susceptibility
patterns of MRSA can be useful in decreasing the incidence
rates.
Finally, it appears that SCCmec typing provides useful
information for determining the epidemiological relation-
ship of a group of MRSA isolates, recovered from hospi-
tals and/or community in Iran. To determine the exact an-
timicrobial susceptibility profiles and encoding resistance
genes among MRSA isolates in the community and hos-
pital settings of Iran, comprehensive research and large-
scale studies are needed to provide further information
on the phenotypic and genotypic characteristics of MRSA.
Also, effective infection management for controlling the
spread of CA-MRSA infections is highly recommended.
It should be noted that the positive control strains
for SCCmec typing were donated by Amir Azimian (depart-
ment of pathobiology and anatomy, school of medicine,
North Khorasan University of Medical Sciences, Bojnord,
Iran).
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